Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Mag 2** is a French Cooper Consumer Health over-the-counter consumer-health brand covering multiple magnesium-containing products rather than one uniquely defined chemical entity. The range includes authorized oral medicines such as MAG 2 100 mg tablets containing magnesium carbonate and MAG 2 oral solution or sachet products containing magnesium pidolate, as well as dietary-supplement variants containing magnesium with ingredients such as vitamins, taurine, melatonin, or botanical extracts. The authorized MAG 2 100 mg tablet is used for symptoms that may suggest magnesium deficiency, including transient fatigue, mild anxiety or irritability, minor sleep disturbance, muscle cramps, and paresthesia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Mag 2.